Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Summary of Recommendations (all are conditional)
SLEa | ||||
RA, SpA including AS and PsA | JIA | Nonbiologic DMARDs | SLE | Severe SLE |
✓ | ✓ | ✓ |
SLEa | ||||
RA, SpA including AS and PsA | JIA | Nonbiologic DMARDs | SLE | Severe SLE |
✓ | ✓ | ✓ |
SLEa | ||||
RA, SpA including AS and PsA | JIA | Nonbiologic DMARDs | SLE | Severe SLE |
✓ | ✓ |
SLEa | ||||
RA, SpA including AS and PsA | JIA | Nonbiologic DMARDs | SLE | Severe SLE |
✓ |
SLEa | ||||
RA, SpA including AS and PsA | JIA | Nonbiologic DMARDs | SLE | Severe SLE |
✓ |
SLEa | ||||
RA, SpA including AS and PsA | JIA | Nonbiologic DMARDs | SLE | Severe SLE |
✓ | ✓ | ✓ |
SLEa | ||||
RA, SpA including AS and PsA | JIA | Nonbiologic DMARDs | SLE | Severe SLE |
✓ | ✓ |
Recommendation Grading
Disclaimer
Overview
Title
Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Authoring Organizations
American Association of Hip and Knee Surgeons
American College of Rheumatology
Publication Month/Year
June 20, 2022
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
Develop a guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid arthritis (RA), spondyloarthritis (SpA) including ankylosing spondylitis and psoriatic arthritis, juvenile idiopathic arthritis (JIA), or systemic lupus erythematosus (SLE) undergoing elective total hip (THA) or total knee arthroplasty (TKA)
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Hospital, Operating and recovery room
Intended Users
Nurse, nurse practitioner, physical therapist, physician, physician assistant
Scope
Management, Prevention
Diseases/Conditions (MeSH)
D019645 - Arthroplasty, Replacement, Knee, D019990 - Perioperative Care, D001178 - Arthroplasty, D012216 - Rheumatic Diseases
Keywords
total knee arthroplasty, perioperative care, elective total hip, TKA, rheumatic diseases, Antirheumatic Medication
Source Citation
Goodman SM, Springer BD, Chen AF, Davis M, Fernandez DR, Figgie M, Finlayson H, George MD, Giles JT, Gilliland J, Klatt B, MacKenzie R, Michaud K, Miller A, Russell L, Sah A, Abdel MP, Johnson B, Mandl LA, Sculco P, Turgunbaev M, Turner AS, Yates A Jr, Singh JA. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Care Res (Hoboken). 2022 Jun 19. doi: 10.1002/acr.24893. Epub ahead of print. PMID: 35718887.